Evidence map›Paper›PMID 40910070›Full record

ReviewAutophagy reports2025

Autophagy and Bacterial infections.

Ken Cadwell, Clara Abraham, Shai Bel, Santosh Chauhan, Jörn Coers, María I Colombo, Jacob R Davis, Daniel Hofius, Hang Thi Thu Nguyen, Michinaga Ogawa and 11 more

Abstract readReview
In one paragraph

Review in Autophagy reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Autophagy modulation in cancer.Nature reviews. Drug discovery · 2026
    Review
  4. RNF213-dependent lytic destruction ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Regulation of Innate Immune Signaling by Autophagy.International journal of molecular sciences · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ken CadwellDivision of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-5860-0661
Clara AbrahamDepartment of Internal Medicine, Yale University, New Haven, CT, USA.
Shai BelAzrieli Faculty of Medicine, Bar-ilan University, Safed, Israel.
Santosh ChauhanCell Biology and Infectious Diseases Unit, CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
Jörn CoersDepartments of Molecular Genetics and Microbiology and Integrative Immunobiology, Duke University Medical School, Durham, NC, USA.
María I ColomboSchool of Medicine, Laboratory of molecular mechanisms involved in vesicular trafficking and autophagy, IHEM-CONICET- Universidad Nacional de Cuyo, Mendoza, Argentina.
Jacob R DavisDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health, College of Medicine, Bryan, TX, USA.
Daniel HofiusDepartment of Plant Biology, Uppsala BioCenter, Swedish University of Agricultural Sciences (SLU), Uppsala, Sweden.
Hang Thi Thu NguyenM2iSH (Microbes, intestine, inflammation and Susceptibility of the Host), U1071 Inserm, University of Clermont Auvergne, INRAE USC 1382, Clermont-Ferrand, France.
Michinaga OgawaDepartment of Bacteriology I, National Institute of Infectious Diseases, JIHS, Tokyo, Japan.
Craig R RoyDepartment of Microbial Pathogenesis, School of Medicine, Yale University, New Haven, CT, USA.
Feng ShaoNational Institute of Biological Sciences, Beijing, China.
Sayaka ShizukuishiDepartment of Bacteriology I, National Institute of Infectious Diseases, JIHS, Tokyo, Japan.
Christina L StallingsDepartment of Molecular Microbiology, Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, USA.
Magdalena SzczesnaDepartment of Infectious Disease, Centre for Bacterial Resistance Biology, Imperial College London, London, UK.
Gergory TaylorDepartments of Medicine, Molecular Genetics and Microbiology, and the Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA.
Teresa Lm ThurstonSir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Robert WatsonDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA.
Thomas WilemanBiomedical Research Centre, Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK.
Yue XuDepartment of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dario S ZamboniDepartment of Cell Biology, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.

Funding

RP5: Chemical proteomic discovery of small-molecule probes for autophagy proteinsU19AI142784 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI XAVIER, RAMNIK J · 2019 to 2023
$36.9M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GARY D. WU · 1997 to 2026
$32.5M
Diabetes, Digestive, and Kidney Diseases Extramural ResearchR01DK093668 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 2011 to 2026
$7.3M
Functional outcomes of inflammatory bowel disease associated variantsR01DK099097 · NIDDK · YALE UNIVERSITY · PI CLARA ABRAHAM · 2013 to 2026
$7.0M
Redefining the role of autophagy in bacterial diseaseR01AI121244 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 2017 to 2026
$5.6M
IRGM-driven host responses to Chlamydia trachomatis infectionsR01AI103197 · NIAID · DUKE UNIVERSITY · PI COERS, JOERN · 2013 to 2023
$4.2M
Interferon-inducible cell-autonomous immunity to cytosolic bacterial pathogensR01AI139425 · NIAID · DUKE UNIVERSITY · PI Jorn Coers · 2019 to 2026
$3.4M
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infectionR01AI155621 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATRICK, KRISTIN LEIGH, WATSON, ROBERT OWEN · 2021 to 2025
$2.9M
Autophagy proteins in the immune response to Mycobacterium tuberculosis infectionR01AI132697 · NIAID · WASHINGTON UNIVERSITY · PI STALLINGS, CHRISTINA LEIGH · 2019 to 2023
$2.4M
IRGM proteins as regulators of inflammationR01AI148243 · NIAID · DUKE UNIVERSITY · PI COERS, JOERN, TAYLOR, GREGORY A · 2020 to 2024
$2.4M
Interactions between Trichuris and the gut microbiotaR01AI179896 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell, E. Jane Albert Hubbard · 2024 to 2026
$2.0M
Interferon-inducible cell-intrinsic host defense against Chlamydia trachomatisR37AI103197 · NIAID · DUKE UNIVERSITY · PI Jorn Coers · 2024 to 2026
$1.6M
NIAID NIH HHS R01 AI103197NIAID NIH HHS R01 AI121244NIAID NIH HHS R01 AI132697NIAID NIH HHS R01 AI139425NIAID NIH HHS R01 AI148243NIAID NIH HHS R01 AI155621NIAID NIH HHS R01 AI179896NIAID NIH HHS R37 AI103197NIAID NIH HHS R56 AI182383NIAID NIH HHS U19 AI142784NIDDK NIH HHS P30 DK050306NIDDK NIH HHS R01 DK093668NIDDK NIH HHS R01 DK099097
6 · The paper itself

Abstract

Autophagy is an evolutionarily conserved cellular process that is prominent during bacterial infections. In this review article, we discuss how direct pathogen clearance via xenophagy and regulation of inflammatory products represent dual functions of autophagy that coordinate an effective antimicrobial response. We detail the molecular mechanisms of xenophagy, including signals that indicate the presence of an intracellular pathogen and autophagy receptor-mediated cargo targeting, while highlighting pathogen counterstrategies, such as bacterial effector proteins that inhibit autophagy initiation or exploit autophagic membranes for replication. Pathways that are related to autophagy, including LC3-associated phagocytosis (LAP) and conjugation of ATG8 to single membranes (CASM), are expanding the role of autophagy in antimicrobial defense beyond traditional double-membrane autophagosomes. Examination of Crohn disease-associated genes links impaired autophagy to inflammation and defective bacterial handling. We propose emerging concepts, such as effector-triggered immunity, where autophagy inhibition by pathogens triggers inflammatory defenses and discusses the therapeutic potential of modulating autophagy in infectious and inflammatory diseases.

Indexed as

AutophagybacteriaCASMCrohn diseaseLC3 associated phagocytosisxenophagy

Identifiers

PMID40910070
PMCPMC12407897

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.